Outcome-specific shifts in homocysteine-androgen correlations in polycystic ovary syndrome - Top-Institutions - MDSpire

Outcome-specific shifts in homocysteine-androgen correlations in polycystic ovary syndrome

  • By

  • Qian Han

  • Jiarun Zhao

  • Mengyuan Li

  • Mingwei Xin

  • Xiaodan Yin

  • Junqin He

  • April 7, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Reproductive Endocrinology
    • Metabolic Disorders
    • Women's Health

  • #2

    Massachusetts General Hospital (MGH) - Harvard Medical School
    Massachusetts General Hospital (MGH) - Harvard Medical School

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Obstetrics and Gynecology
    • Metabolic Research

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Reproductive Endocrinology
    • Metabolism
    • Obstetrics and Gynecology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Endocrinology
    • Reproductive Medicine
    • Metabolic Disorders

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Obstetrics and Gynecology
    • Metabolic Research

Original Source(s)

Outcome-specific shifts in homocysteine-androgen correlations in polycystic ovary syndrome

  • by Qian Han, Jiarun Zhao, Mengyuan Li, Mingwei Xin, Xiaodan Yin, Junqin He

  • April 7, 2026

Related Content

Non-linear saturation threshold of gonadotropin dose on cumulative live birth rates in advanced-age women with polycystic ovary syndrome: a retrospective cohort study

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

Integrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications